1[1]Sharrett AR,Ballantyne CM,Coady SA,et al.Coronary heart disease prediction from lipoprotein cholesterol levels,triglycerides,lipoprotein (a),apolipoproteins A- I and B,and HDL density subfractions:The Atherosclerosis Risk in Communities (ARIC) Study.Circulation,2001,104(10) :1108
2[2]Shepherd J,Cobe SM,Ford I,et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia:West of Scotland Coronary Prevention Study Group.N Engl J Med,1995,333:1301 - 1307
3[3]Shah PK,Yano J,Reyes O,et al.High - dose recombinant apolipoprotein A - I Milano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in aplipoprotein E - deficient mice:potential implications for acute plaque stabilization.Circulation,2001,103:3047 - 3050
4[4]Navab M,Hama SY,Cooke CJ,et al.Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein:step 2 and 3.J lipid Res ,2000,41:1495 - 1508
5[5]Mackness MI,Sangvanich P,Mackness B,et al.HDL prevents the formation of aldehyde adducts of apolipoprotein B during the oxidation of LDL.Atherosclerosis,2000,151:260
